BRIMONIDINE TARTRATE

BRIMONIDINE TARTRATE was reported 17166 times

These side effects are most commonly reported by patients taking BRIMONIDINE TARTRATE:

# Side effect Count
0 TREATMENT FAILURE 2879
1 DRUG INEFFECTIVE 1311
2 EYE IRRITATION 812
3 EYE PAIN 789
4 OCULAR HYPERAEMIA 779
5 ERYTHEMA 763
6 FATIGUE 722
7 OFF LABEL USE 716
8 HYPERSENSITIVITY 699
9 VISION BLURRED 656
10 INTRAOCULAR PRESSURE INCREASED 626
11 DIZZINESS 593
12 HEADACHE 558
13 CONDITION AGGRAVATED 498
14 DIARRHOEA 485
15 DYSPNOEA 447
16 NAUSEA 431
17 DEATH 429
18 FALL 407
19 VISUAL IMPAIRMENT 404
20 GLAUCOMA 382
21 ASTHENIA 376
22 PAIN 354
23 PRURITUS 349
24 PRODUCT USE ISSUE 340
25 PRODUCT DOSE OMISSION ISSUE 335
26 EYE PRURITUS 334
27 DRUG HYPERSENSITIVITY 328
28 RASH 323
29 FLUSHING 312
30 DRY EYE 307
31 SOMNOLENCE 301
32 PNEUMONIA 292
33 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 284
34 COUGH 281
35 MALAISE 281
36 CATARACT 257
37 ARTHRALGIA 249
38 HYPOTENSION 237
39 VOMITING 230
40 EYE SWELLING 228
41 PAIN IN EXTREMITY 225
42 INCORRECT DOSE ADMINISTERED 218
43 LACRIMATION INCREASED 216
44 DRY MOUTH 215
45 WEIGHT DECREASED 213
46 URINARY TRACT INFECTION 209
47 VISUAL ACUITY REDUCED 204
48 HYPERTENSION 203
49 DECREASED APPETITE 201
50 CONSTIPATION 197
51 ACCIDENTAL EXPOSURE TO PRODUCT 194
52 ACUTE KIDNEY INJURY 193
53 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 193
54 SKIN BURNING SENSATION 189
55 INSOMNIA 187
56 PYREXIA 187
57 ROSACEA 183
58 BLOOD PRESSURE INCREASED 177
59 ANAEMIA 174
60 CHRONIC KIDNEY DISEASE 173
61 EYE DISORDER 173
62 FEELING HOT 171
63 BACK PAIN 170
64 PERIPHERAL SWELLING 170
65 CONFUSIONAL STATE 167
66 GAIT DISTURBANCE 162
67 PRODUCT CONTAINER ISSUE 161
68 ABDOMINAL PAIN 154
69 BLINDNESS 151
70 PRODUCT STORAGE ERROR 151
71 PRODUCT USE IN UNAPPROVED INDICATION 149
72 ATRIAL FIBRILLATION 148
73 PRODUCT QUALITY ISSUE 148
74 RENAL FAILURE 148
75 FEELING ABNORMAL 147
76 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147
77 ANXIETY 145
78 DRUG INTOLERANCE 145
79 DEPRESSION 144
80 CONJUNCTIVITIS 142
81 REBOUND EFFECT 142
82 BRADYCARDIA 140
83 PHOTOPHOBIA 137
84 ABDOMINAL PAIN UPPER 132
85 FOREIGN BODY SENSATION IN EYES 131
86 WEIGHT INCREASED 131
87 BURNING SENSATION 127
88 DRY SKIN 126
89 EYE DISCHARGE 125
90 ALOPECIA 123
91 BALANCE DISORDER 123
92 BLINDNESS UNILATERAL 123
93 PARAESTHESIA 122
94 OCULAR DISCOMFORT 120
95 DRUG DOSE OMISSION 119
96 CHEST PAIN 117
97 BLOOD GLUCOSE INCREASED 115
98 SWELLING FACE 115
99 LOSS OF CONSCIOUSNESS 114
100 NASOPHARYNGITIS 114
101 ABDOMINAL DISCOMFORT 112
102 DEHYDRATION 112
103 MUSCULAR WEAKNESS 112
104 TREMOR 111
105 BLOOD PRESSURE DECREASED 109
106 COVID-19 109
107 CEREBROVASCULAR ACCIDENT 108
108 PALPITATIONS 108
109 ASTHMA 107
110 CORNEAL OPACITY 107
111 DEPRESSED LEVEL OF CONSCIOUSNESS 107
112 HAEMOGLOBIN DECREASED 107
113 MUSCLE SPASMS 107
114 NO ADVERSE EVENT 107
115 EYE INFLAMMATION 106
116 OEDEMA PERIPHERAL 106
117 MEDICATION ERROR 105
118 HYPOAESTHESIA 104
119 RASH MACULAR 104
120 RHINORRHOEA 104
121 MEMORY IMPAIRMENT 101
122 SINUSITIS 101
123 SYNCOPE 101
124 NASAL CONGESTION 100
125 ERYTHEMA OF EYELID 98
126 LETHARGY 96
127 ADVERSE DRUG REACTION 94
128 SKIN EXFOLIATION 94
129 MYALGIA 93
130 PRODUCT PACKAGING QUANTITY ISSUE 93
131 INTENTIONAL PRODUCT MISUSE 92
132 CORNEAL OEDEMA 91
133 PRODUCT DOSE OMISSION 90
134 UVEITIS 90
135 DRUG INTERACTION 88
136 HALLUCINATION 87
137 INFECTION 85
138 INFLUENZA 85
139 GASTROINTESTINAL HAEMORRHAGE 84
140 HOT FLUSH 84
141 SKIN IRRITATION 84
142 INJECTION SITE PAIN 83
143 NEUROPATHY PERIPHERAL 83
144 TOXICITY TO VARIOUS AGENTS 83
145 CHEST DISCOMFORT 81
146 CONTUSION 81
147 URTICARIA 80
148 CONJUNCTIVAL HYPERAEMIA 79
149 INFLAMMATION 79
150 VERTIGO 79
151 DYSGEUSIA 78
152 HOSPITALISATION 77
153 MYOCARDIAL INFARCTION 77
154 CHILLS 76
155 RHEUMATOID ARTHRITIS 76
156 THERAPY INTERRUPTED 76
157 VITREOUS FLOATERS 76
158 JOINT SWELLING 75
159 PRODUCT DELIVERY MECHANISM ISSUE 75
160 INTENTIONAL PRODUCT USE ISSUE 74
161 PAIN OF SKIN 74
162 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 73
163 DYSPEPSIA 73
164 SWELLING 73
165 DYSPHONIA 72
166 GASTROOESOPHAGEAL REFLUX DISEASE 72
167 HEART RATE INCREASED 72
168 PALLOR 72
169 EPISTAXIS 71
170 PRODUCT USE COMPLAINT 71
171 DISCOMFORT 69
172 CARDIAC FAILURE CONGESTIVE 68
173 END STAGE RENAL DISEASE 68
174 DISEASE PROGRESSION 67
175 HYPERHIDROSIS 67
176 ARTHRITIS 66
177 EMOTIONAL DISTRESS 66
178 SEPSIS 66
179 DYSPHAGIA 65
180 OROPHARYNGEAL PAIN 65
181 RASH ERYTHEMATOUS 65
182 BLISTER 64
183 CELLULITIS 64
184 GENERAL PHYSICAL HEALTH DETERIORATION 64
185 SKIN DISCOLOURATION 64
186 OEDEMA 63
187 THERAPY NON-RESPONDER 63
188 VISUAL FIELD DEFECT 63
189 HEART RATE DECREASED 61
190 IRIDOCYCLITIS 61
191 THROMBOCYTOPENIA 61
192 UNEVALUABLE EVENT 61
193 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60
194 COMA 60
195 EXPIRED PRODUCT ADMINISTERED 60
196 EYE INFECTION 60
197 CARDIAC DISORDER 59
198 BLOOD CREATININE INCREASED 58
199 EYELID OEDEMA 58
200 HYPONATRAEMIA 58
201 HYPOTHYROIDISM 58
202 PLATELET COUNT DECREASED 58
203 RETINAL DETACHMENT 58
204 ACNE 57
205 BLEPHARITIS 57
206 FLUID RETENTION 57
207 OVERDOSE 57
208 WHITE BLOOD CELL COUNT DECREASED 57
209 ADVERSE EVENT 56
210 MACULAR OEDEMA 56
211 ABDOMINAL DISTENSION 55
212 BRONCHITIS 55
213 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55
214 RENAL IMPAIRMENT 55
215 OSTEOARTHRITIS 54
216 SLEEP DISORDER 54
217 STRESS 54
218 DIABETES MELLITUS 53
219 HAEMORRHAGE 53
220 OXYGEN SATURATION DECREASED 53
221 SEIZURE 53
222 SURGERY 53
223 HYPOACUSIS 52
224 SWELLING OF EYELID 52
225 THROMBOSIS 52
226 TINNITUS 52
227 BLOOD PRESSURE FLUCTUATION 51
228 OCULAR HYPERTENSION 51
229 MIGRAINE 50
230 PRODUCT ADMINISTRATION ERROR 50
231 SKIN WARM 50
232 EYE HAEMORRHAGE 49
233 NEPHROGENIC ANAEMIA 49
234 NEUTROPENIA 49
235 TREATMENT NONCOMPLIANCE 49
236 CARDIAC FAILURE 48
237 FLATULENCE 48
238 GASTROINTESTINAL DISORDER 48
239 RESPIRATORY FAILURE 48
240 DERMATITIS 47
241 DIPLOPIA 47
242 EYE OPERATION 47
243 TACHYCARDIA 47
244 PRODUCT SUBSTITUTION ISSUE 46
245 THROAT IRRITATION 46
246 EYELID PAIN 45
247 MENISCUS INJURY 45
248 OCULAR SURFACE DISEASE 45
249 PSORIASIS 45
250 PULMONARY EMBOLISM 45
251 RASH PAPULAR 45
252 DRUG EFFECT DECREASED 44
253 HAEMATOCHEZIA 44
254 HYPOGLYCAEMIA 44
255 ILLNESS 44
256 POLLAKIURIA 44
257 THERAPEUTIC RESPONSE DECREASED 44
258 UNDERDOSE 44
259 APPLICATION SITE ERYTHEMA 43
260 DYSPNOEA EXERTIONAL 43
261 RENAL DISORDER 43
262 AMNESIA 42
263 EYELID PTOSIS 42
264 HYPOTONIA 42
265 PRODUCT DROPPER ISSUE 42
266 PRODUCTIVE COUGH 42
267 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42
268 ABNORMAL SENSATION IN EYE 41
269 DEEP VEIN THROMBOSIS 41
270 EYELIDS PRURITUS 41
271 HERPES ZOSTER 41
272 HYPOPHAGIA 41
273 NEPHROLITHIASIS 41
274 THERAPEUTIC RESPONSE UNEXPECTED 41
275 WHEEZING 41
276 CARDIAC ARREST 40
277 CHOROIDAL EFFUSION 40
278 MACULAR DEGENERATION 40
279 MUSCULOSKELETAL STIFFNESS 40
280 NECK PAIN 40
281 DEPRESSED MOOD 39
282 EYELID IRRITATION 39
283 EYELID MARGIN CRUSTING 39
284 LIP SWELLING 39
285 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39
286 MENTAL STATUS CHANGES 39
287 OPEN ANGLE GLAUCOMA 39
288 RASH PRURITIC 39
289 RENAL INJURY 39
290 ARRHYTHMIA 38
291 BONE PAIN 38
292 EXTRA DOSE ADMINISTERED 38
293 HYPOXIA 38
294 NERVOUSNESS 38
295 CORNEAL DISORDER 37
296 EYE ALLERGY 37
297 HYPERGLYCAEMIA 37
298 PLEURAL EFFUSION 37
299 WRONG PRODUCT ADMINISTERED 37
300 AGITATION 36
301 DERMATITIS CONTACT 36
302 MALIGNANT NEOPLASM PROGRESSION 36
303 MOBILITY DECREASED 36
304 STOMATITIS 36
305 ARTHROPATHY 35
306 BLOOD CHOLESTEROL INCREASED 35
307 DEVICE ISSUE 35
308 HYPOTHERMIA 35
309 PULMONARY OEDEMA 35
310 SCLERAL HYPERAEMIA 35
311 AGEUSIA 34
312 CHOROIDAL DETACHMENT 34
313 CONJUNCTIVITIS ALLERGIC 34
314 DYSURIA 34
315 LUNG DISORDER 34
316 MUSCULOSKELETAL PAIN 34
317 ANGLE CLOSURE GLAUCOMA 33
318 BLOOD GLUCOSE DECREASED 33
319 FEELING COLD 33
320 HYPERKALAEMIA 33
321 IRRITABILITY 33
322 RED BLOOD CELL COUNT DECREASED 33
323 SKIN ULCER 33
324 VITREOUS HAEMORRHAGE 33
325 INFLUENZA LIKE ILLNESS 32
326 RECTAL HAEMORRHAGE 32
327 RIB FRACTURE 32
328 SKIN DISORDER 32
329 SPEECH DISORDER 32
330 DEMENTIA 31
331 HIP FRACTURE 31
332 PHOTOPSIA 31
333 RENAL FAILURE ACUTE 31
334 ACTIVITIES OF DAILY LIVING IMPAIRED 30
335 APPLICATION SITE PAIN 30
336 ASTHENOPIA 30
337 DEAFNESS 30
338 DYSARTHRIA 30
339 HYPERSOMNIA 30
340 NOCTURIA 30
341 PANCYTOPENIA 30
342 TRANSIENT ISCHAEMIC ATTACK 30
343 ASPARTATE AMINOTRANSFERASE INCREASED 29
344 BLINDNESS TRANSIENT 29
345 BLOOD CREATINE PHOSPHOKINASE INCREASED 29
346 CYSTITIS 29
347 ENDOPHTHALMITIS 29
348 INJECTION SITE HAEMORRHAGE 29
349 INTENTIONAL DOSE OMISSION 29
350 NIGHT SWEATS 29
351 PAIN IN JAW 29
352 SNEEZING 29
353 URINARY INCONTINENCE 29
354 BLOOD MAGNESIUM DECREASED 28
355 HALLUCINATION, VISUAL 28
356 HEPATIC ENZYME INCREASED 28
357 HYPOKALAEMIA 28
358 HYPOTONY OF EYE 28
359 INTRAOCULAR PRESSURE TEST ABNORMAL 28
360 LIMB INJURY 28
361 MYDRIASIS 28
362 CYSTOID MACULAR OEDEMA 27
363 ECZEMA 27
364 GAIT INABILITY 27
365 HAEMATEMESIS 27
366 LOCALISED INFECTION 27
367 MIOSIS 27
368 NIGHTMARE 27
369 PRODUCT DOSE OMISSION IN ERROR 27
370 PRODUCT PACKAGING ISSUE 27
371 ULCERATIVE KERATITIS 27
372 BLOOD UREA INCREASED 26
373 BODY HEIGHT DECREASED 26
374 CATARACT OPERATION 26
375 CORNEAL TRANSPLANT 26
376 HAEMATOCRIT DECREASED 26
377 HAEMATURIA 26
378 HEART RATE IRREGULAR 26
379 IMPAIRED HEALING 26
380 IRITIS 26
381 MIDDLE INSOMNIA 26
382 OSTEOPOROSIS 26
383 PRODUCT CLOSURE REMOVAL DIFFICULT 26
384 RETINAL HAEMORRHAGE 26
385 ROAD TRAFFIC ACCIDENT 26
386 THERAPY CESSATION 26
387 UNRESPONSIVE TO STIMULI 26
388 URINARY RETENTION 26
389 WOUND 26
390 BLOOD PRESSURE ABNORMAL 25
391 DRUG EFFECT INCOMPLETE 25
392 DYSSTASIA 25
393 ELECTROLYTE IMBALANCE 25
394 FUNGAL INFECTION 25
395 HYPERPARATHYROIDISM SECONDARY 25
396 HYPOMAGNESAEMIA 25
397 INTERNATIONAL NORMALISED RATIO INCREASED 25
398 PULMONARY HYPERTENSION 25
399 PUNCTATE KERATITIS 25
400 BLOOD POTASSIUM DECREASED 24
401 DIVERTICULITIS 24
402 DRY THROAT 24
403 EAR PAIN 24
404 EYE INJURY 24
405 FREQUENT BOWEL MOVEMENTS 24
406 GROWTH OF EYELASHES 24
407 HAEMOPTYSIS 24
408 HEAD DISCOMFORT 24
409 HEAD INJURY 24
410 HEMIPARESIS 24
411 HOSPICE CARE 24
412 JOINT INJURY 24
413 LIMB DISCOMFORT 24
414 METABOLIC ACIDOSIS 24
415 NASAL DRYNESS 24
416 PANCREATITIS 24
417 PHARYNGITIS 24
418 PLASMA CELL MYELOMA 24
419 RESPIRATORY DISORDER 24
420 SUPERFICIAL INJURY OF EYE 24
421 ACCIDENTAL OVERDOSE 23
422 ANAPHYLACTIC REACTION 23
423 DYSKINESIA 23
424 EAR INFECTION 23
425 ENCEPHALOPATHY 23
426 EPILEPSY 23
427 FULL BLOOD COUNT DECREASED 23
428 HAEMORRHOIDS 23
429 INFUSION RELATED REACTION 23
430 INTERVERTEBRAL DISC PROTRUSION 23
431 KERATITIS 23
432 ORAL PAIN 23
433 PNEUMONITIS 23
434 REACTION TO PRESERVATIVES 23
435 SEPTIC SHOCK 23
436 SUICIDAL IDEATION 23
437 SWOLLEN TONGUE 23
438 THERAPEUTIC PRODUCT EFFECT DECREASED 23
439 UPPER RESPIRATORY TRACT INFECTION 23
440 CONTRAINDICATED PRODUCT ADMINISTERED 22
441 DISORIENTATION 22
442 ELECTROCARDIOGRAM QT PROLONGED 22
443 IMPAIRED DRIVING ABILITY 22
444 ORTHOSTATIC HYPOTENSION 22
445 PERIORBITAL SWELLING 22
446 PHOTOSENSITIVITY REACTION 22
447 RESTLESSNESS 22
448 SEASONAL ALLERGY 22
449 SKIN DISCOMFORT 22
450 SKIN TIGHTNESS 22
451 UPPER LIMB FRACTURE 22
452 VITAMIN D DECREASED 22
453 VITREOUS DETACHMENT 22
454 ACUTE MYOCARDIAL INFARCTION 21
455 BLOOD POTASSIUM INCREASED 21
456 COLITIS 21
457 CORNEAL NEOVASCULARISATION 21
458 DYSLIPIDAEMIA 21
459 EYELID DISORDER 21
460 GASTRIC DISORDER 21
461 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21
462 INJECTION SITE ERYTHEMA 21
463 ISCHAEMIC STROKE 21
464 MELAENA 21
465 PERIPHERAL COLDNESS 21
466 PNEUMONIA ASPIRATION 21
467 POOR QUALITY PRODUCT ADMINISTERED 21
468 POST PROCEDURAL COMPLICATION 21
469 PRODUCT PACKAGING DIFFICULT TO OPEN 21
470 RESPIRATORY DISTRESS 21
471 RESPIRATORY TRACT CONGESTION 21
472 SCAB 21
473 SINUS DISORDER 21
474 STAPHYLOCOCCAL INFECTION 21
475 WHITE BLOOD CELL COUNT INCREASED 21
476 BLOOD PRESSURE SYSTOLIC INCREASED 20
477 BLOOD URINE PRESENT 20
478 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20
479 CONJUNCTIVAL HAEMORRHAGE 20
480 CORONARY ARTERY DISEASE 20
481 DISTURBANCE IN ATTENTION 20
482 FEBRILE NEUTROPENIA 20
483 GASTRITIS 20
484 HAEMATOMA 20
485 INJECTION SITE PRURITUS 20
486 INJURY 20
487 INTRAOCULAR PRESSURE DECREASED 20
488 LARGE INTESTINE POLYP 20
489 MASS 20
490 OSTEOMYELITIS 20
491 PARKINSON^S DISEASE 20
492 PRODUCT AVAILABILITY ISSUE 20
493 RETINAL DISORDER 20
494 VASCULITIS 20
495 ARTERIOSCLEROSIS CORONARY ARTERY 19
496 DERMATITIS ALLERGIC 19
497 DEVICE DIFFICULT TO USE 19
498 DIZZINESS POSTURAL 19
499 FACIAL PAIN 19
500 IRIS ADHESIONS 19
501 MENTAL DISORDER 19
502 MOVEMENT DISORDER 19
503 NEOPLASM MALIGNANT 19
504 NEURALGIA 19
505 NEUTROPHIL COUNT DECREASED 19
506 OCULAR VASCULAR DISORDER 19
507 RECALLED PRODUCT ADMINISTERED 19
508 RETCHING 19
509 SLEEP APNOEA SYNDROME 19
510 THROAT TIGHTNESS 19
511 ALANINE AMINOTRANSFERASE INCREASED 18
512 BACK DISORDER 18
513 CORNEAL INFILTRATES 18
514 DRUG ADMINISTRATION ERROR 18
515 GOUT 18
516 HYPERAEMIA 18
517 ILL-DEFINED DISORDER 18
518 INJECTION SITE BRUISING 18
519 INTERSTITIAL LUNG DISEASE 18
520 LABORATORY TEST ABNORMAL 18
521 PRODUCT COMPLAINT 18
522 PRODUCT CONTAINER SEAL ISSUE 18
523 PRODUCT DISPENSING ERROR 18
524 PURPURA 18
525 RESPIRATORY DEPRESSION 18
526 RETINAL ARTERY OCCLUSION 18
527 APATHY 17
528 APHASIA 17
529 BASAL CELL CARCINOMA 17
530 BRAIN FOG 17
531 CEREBRAL HAEMORRHAGE 17
532 CLOSTRIDIUM DIFFICILE INFECTION 17
533 CORNEAL DEPOSITS 17
534 DERMATITIS ATOPIC 17
535 ECONOMIC PROBLEM 17
536 ERECTILE DYSFUNCTION 17
537 FEMUR FRACTURE 17
538 GLOMERULAR FILTRATION RATE DECREASED 17
539 HYPERKERATOSIS 17
540 HYPOKINESIA 17
541 INJECTION SITE SWELLING 17
542 INSTILLATION SITE ERYTHEMA 17
543 INSTILLATION SITE PAIN 17
544 INTRAOCULAR PRESSURE FLUCTUATION 17
545 MULTIPLE SCLEROSIS 17
546 MUSCULOSKELETAL DISCOMFORT 17
547 PRODUCT PRESCRIBING ISSUE 17
548 PRURITUS GENERALISED 17
549 PULMONARY MASS 17
550 SCIATICA 17
551 ANTERIOR CHAMBER INFLAMMATION 16
552 BLOOD SODIUM DECREASED 16
553 BONE DENSITY DECREASED 16
554 COGNITIVE DISORDER 16
555 CUTANEOUS VASCULITIS 16
556 DELUSION 16
557 ENDOCRINE OPHTHALMOPATHY 16
558 EXPOSURE VIA SKIN CONTACT 16
559 FOOT DEFORMITY 16
560 HORDEOLUM 16
561 HYPOAESTHESIA ORAL 16
562 HYPOCALCAEMIA 16
563 INSTILLATION SITE IRRITATION 16
564 INSURANCE ISSUE 16
565 IRON DEFICIENCY ANAEMIA 16
566 LACTIC ACIDOSIS 16
567 LUNG NEOPLASM MALIGNANT 16
568 OPTIC NEURITIS 16
569 ORAL HERPES 16
570 PRODUCT LABEL ISSUE 16
571 PRODUCT PRESCRIBING ERROR 16
572 RESPIRATORY TRACT INFECTION 16
573 RETINAL VEIN OCCLUSION 16
574 SKIN SWELLING 16
575 TASTE DISORDER 16
576 TOOTH DISORDER 16
577 ANGINA PECTORIS 15
578 APNOEA 15
579 BACTERIAL INFECTION 15
580 BEHCET^S SYNDROME 15
581 BLADDER DISORDER 15
582 CHOLELITHIASIS 15
583 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15
584 DEVICE MALFUNCTION 15
585 DIABETIC RETINOPATHY 15
586 EMPHYSEMA 15
587 EYE COLOUR CHANGE 15
588 GLUCOSE TOLERANCE IMPAIRED 15
589 GLYCOSYLATED HAEMOGLOBIN INCREASED 15
590 HAEMORRHAGIC STROKE 15
591 HYPERSENSITIVITY VASCULITIS 15
592 HYPHAEMA 15
593 KNEE ARTHROPLASTY 15
594 LIQUID PRODUCT PHYSICAL ISSUE 15
595 MOUTH ULCERATION 15
596 MULTIPLE SCLEROSIS RELAPSE 15
597 MYOSITIS 15
598 ONYCHOCLASIS 15
599 OPTIC NERVE INJURY 15
600 PALPABLE PURPURA 15
601 PARAESTHESIA ORAL 15
602 PERICARDIAL EFFUSION 15
603 POOR QUALITY SLEEP 15
604 PRESCRIBED UNDERDOSE 15
605 PRESYNCOPE 15
606 PROSTATE CANCER 15
607 RASH GENERALISED 15
608 RENAL TUBULAR NECROSIS 15
609 SKIN FISSURES 15
610 SUBARACHNOID HAEMORRHAGE 15
611 TRANSFUSION 15
612 UPPER GASTROINTESTINAL HAEMORRHAGE 15
613 ABASIA 14
614 BENIGN PROSTATIC HYPERPLASIA 14
615 BLOOD CALCIUM DECREASED 14
616 BREAST CANCER 14
617 C-REACTIVE PROTEIN INCREASED 14
618 CARDIO-RESPIRATORY ARREST 14
619 CRYING 14
620 DISEASE RECURRENCE 14
621 ELECTRIC SHOCK SENSATION 14
622 FAECES DISCOLOURED 14
623 FIBROADENOMA OF BREAST 14
624 HERNIA 14
625 HIATUS HERNIA 14
626 IMPAIRED QUALITY OF LIFE 14
627 INTERNAL HAEMORRHAGE 14
628 INTESTINAL OBSTRUCTION 14
629 LARYNGITIS 14
630 LYMPHADENOPATHY 14
631 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 14
632 MEIBOMIAN GLAND DYSFUNCTION 14
633 MUSCLE ATROPHY 14
634 OESOPHAGITIS 14
635 OPTIC NEUROPATHY 14
636 PERIORBITAL PAIN 14
637 PROTEINURIA 14
638 PSORIATIC ARTHROPATHY 14
639 PULMONARY ARTERIAL HYPERTENSION 14
640 SKIN INJURY 14
641 SPINAL COMPRESSION FRACTURE 14
642 TENDERNESS 14
643 TOOTHACHE 14
644 TOXIC ANTERIOR SEGMENT SYNDROME 14
645 TYPE 2 DIABETES MELLITUS 14
646 ABNORMAL DREAMS 13
647 ABSCESS 13
648 ACUTE RESPIRATORY FAILURE 13
649 AGGRESSION 13
650 ANGER 13
651 APPLICATION SITE PRURITUS 13
652 ATRIAL FLUTTER 13
653 CARDIOGENIC SHOCK 13
654 CONJUNCTIVAL OEDEMA 13
655 CORNEA VERTICILLATA 13
656 CYANOSIS 13
657 DERMATITIS EXFOLIATIVE GENERALISED 13
658 DEVICE USE ISSUE 13
659 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13
660 EXOSTOSIS 13
661 FEAR 13
662 FEELING JITTERY 13
663 FLUID OVERLOAD 13
664 FRACTURE 13
665 GLARE 13
666 GLOSSODYNIA 13
667 HAEMOGLOBIN ABNORMAL 13
668 HERPES OPHTHALMIC 13
669 HYPERAESTHESIA 13
670 INJECTION SITE REACTION 13
671 INTENTIONAL UNDERDOSE 13
672 JAUNDICE 13
673 JOINT RANGE OF MOTION DECREASED 13
674 KERATOPATHY 13
675 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13
676 LIVER DISORDER 13
677 MENTAL IMPAIRMENT 13
678 METAMORPHOPSIA 13
679 MULTIPLE ALLERGIES 13
680 NEUROLOGICAL SYMPTOM 13
681 PHARYNGEAL SWELLING 13
682 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13
683 PRODUCT DEPOSIT 13
684 PRODUCT PHYSICAL ISSUE 13
685 RASH PUSTULAR 13
686 SKIN HAEMORRHAGE 13
687 SKIN LACERATION 13
688 SUNBURN 13
689 TUBULOINTERSTITIAL NEPHRITIS 13
690 WRIST FRACTURE 13
691 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13
692 ANHEDONIA 12
693 ARTERIOSCLEROSIS 12
694 ATAXIA 12
695 CONCOMITANT DISEASE AGGRAVATED 12
696 CONJUNCTIVAL SCAR 12
697 CONVULSION 12
698 CORNEAL DEGENERATION 12
699 CORNEAL SCAR 12
700 DIABETES MELLITUS INADEQUATE CONTROL 12
701 DISABILITY 12
702 DIVERTICULUM 12
703 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12
704 EATING DISORDER 12
705 EMOTIONAL DISORDER 12
706 EYE MOVEMENT DISORDER 12
707 EYE OEDEMA 12
708 FOREIGN BODY IN EYE 12
709 GALLBLADDER DISORDER 12
710 GASTROENTERITIS 12
711 GASTROENTERITIS VIRAL 12
712 GLAUCOMA SURGERY 12
713 HAIR TEXTURE ABNORMAL 12
714 HEPATIC CIRRHOSIS 12
715 HYPOTONY MACULOPATHY 12
716 INCORRECT DRUG ADMINISTRATION DURATION 12
717 INCORRECT PRODUCT STORAGE 12
718 JOINT DISLOCATION 12
719 LEUKOPENIA 12
720 LIVER FUNCTION TEST ABNORMAL 12
721 MICTURITION URGENCY 12
722 MOOD ALTERED 12
723 MUSCLE TWITCHING 12
724 NASAL DISCOMFORT 12
725 ORAL DISCOMFORT 12
726 PANIC ATTACK 12
727 PROCEDURAL PAIN 12
728 PRODUCT DISPENSING ISSUE 12
729 PRODUCT DISTRIBUTION ISSUE 12
730 PRODUCT RESIDUE PRESENT 12
731 PSYCHOLOGICAL TRAUMA 12
732 RASH MACULO-PAPULAR 12
733 REBOUND ACID HYPERSECRETION 12
734 RENAL CYST 12
735 RESPIRATORY RATE INCREASED 12
736 ROTATOR CUFF SYNDROME 12
737 SENSORY DISTURBANCE 12
738 SPINAL FRACTURE 12
739 SQUAMOUS CELL CARCINOMA 12
740 SUBDURAL HAEMATOMA 12
741 THERAPEUTIC RESPONSE SHORTENED 12
742 UPPER-AIRWAY COUGH SYNDROME 12
743 ABNORMAL LOSS OF WEIGHT 11
744 ANKLE FRACTURE 11
745 ANOSMIA 11
746 BLOOD TEST ABNORMAL 11
747 BODY TEMPERATURE INCREASED 11
748 COLD SWEAT 11
749 CONJUNCTIVAL FOLLICLES 11
750 CORNEAL EROSION 11
751 CORONARY ARTERY OCCLUSION 11
752 CROHN^S DISEASE 11
753 DECREASED ACTIVITY 11
754 DEVICE DEFECTIVE 11
755 DEVICE DISLOCATION 11
756 EAR DISCOMFORT 11
757 ERUCTATION 11
758 EYELID EXFOLIATION 11
759 FIBROMYALGIA 11
760 GASTRIC ULCER 11
761 HAEMORRHAGE INTRACRANIAL 11
762 HAEMORRHAGE URINARY TRACT 11
763 IMMUNOSUPPRESSION 11
764 INCORRECT ROUTE OF DRUG ADMINISTRATION 11
765 LYMPHOPENIA 11
766 MUSCULOSKELETAL CHEST PAIN 11
767 NEOPLASM PROGRESSION 11
768 OPHTHALMIC HERPES ZOSTER 11
769 PELVIC FRACTURE 11
770 RETINAL VASCULAR OCCLUSION 11
771 RETINOPATHY 11
772 SINUS BRADYCARDIA 11
773 SKIN CANCER 11
774 SMALL INTESTINAL HAEMORRHAGE 11
775 SPUTUM DISCOLOURED 11
776 SQUAMOUS CELL CARCINOMA OF SKIN 11
777 TACHYPNOEA 11
778 UROSEPSIS 11
779 VAGINAL HAEMORRHAGE 11
780 VASODILATATION 11
781 VITAMIN D DEFICIENCY 11
782 VITRITIS 11
783 ABNORMAL BEHAVIOUR 10
784 ALTERED STATE OF CONSCIOUSNESS 10
785 APHONIA 10
786 BACTERAEMIA 10
787 BLOOD LOSS ANAEMIA 10
788 BLOOD PRESSURE DIASTOLIC DECREASED 10
789 BONE DISORDER 10
790 CARDIOMEGALY 10
791 CATARACT NUCLEAR 10
792 CHOKING 10
793 CLOSTRIDIUM DIFFICILE COLITIS 10
794 CUSHING^S SYNDROME 10
795 CYST 10
796 CYTOKINE RELEASE SYNDROME 10
797 DACRYOSTENOSIS ACQUIRED 10
798 DEVICE DELIVERY SYSTEM ISSUE 10
799 DIABETIC KETOACIDOSIS 10
800 DRUG DEPENDENCE 10
801 DRUG DISPENSING ERROR 10
802 DRUG PRESCRIBING ERROR 10
803 DRUG WITHDRAWAL SYNDROME 10
804 EXPIRED DRUG ADMINISTERED 10
805 FLOPPY IRIS SYNDROME 10
806 FLUID INTAKE REDUCED 10
807 FORMICATION 10
808 FRUSTRATION TOLERANCE DECREASED 10
809 GROIN PAIN 10
810 HEPATOCELLULAR INJURY 10
811 HYDRONEPHROSIS 10
812 HYPERLIPIDAEMIA 10
813 HYPOPNOEA 10
814 IMPAIRED WORK ABILITY 10
815 INCORRECT DOSE ADMINISTERED BY PRODUCT 10
816 INFUSION SITE ERYTHEMA 10
817 JOINT STIFFNESS 10
818 KERATIC PRECIPITATES 10
819 KIDNEY INFECTION 10
820 LOCAL SWELLING 10
821 LYMPHOCYTE COUNT DECREASED 10
822 MACULOPATHY 10
823 MADAROSIS 10
824 MOOD SWINGS 10
825 MUSCULOSKELETAL DISORDER 10
826 MYOPIA 10
827 NEEDLE ISSUE 10
828 NERVOUS SYSTEM DISORDER 10
829 NIGHT BLINDNESS 10
830 NODULE 10
831 ONYCHOMYCOSIS 10
832 PERIARTHRITIS 10
833 PERIPHERAL VASCULAR DISORDER 10
834 PLATELET COUNT INCREASED 10
835 PRODUCT PACKAGE ASSOCIATED INJURY 10
836 PULMONARY THROMBOSIS 10
837 RESPIRATORY ACIDOSIS 10
838 RESPIRATORY ARREST 10
839 RESTLESS LEGS SYNDROME 10
840 RETINAL TEAR 10
841 RHINITIS 10
842 SENSATION OF FOREIGN BODY 10
843 SKIN LESION 10
844 SPINAL OSTEOARTHRITIS 10
845 STEVENS-JOHNSON SYNDROME 10
846 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10
847 THERAPY CHANGE 10
848 TOOTH INFECTION 10
849 ULCER 10
850 VIRAL INFECTION 10
851 WEIGHT FLUCTUATION 10
852 ANGIOEDEMA 9
853 ANTERIOR CHAMBER CELL 9
854 APPETITE DISORDER 9
855 ATRIOVENTRICULAR BLOCK COMPLETE 9
856 BLOOD CHLORIDE INCREASED 9
857 BLOOD IRON DECREASED 9
858 BLOOD PRESSURE DIASTOLIC ABNORMAL 9
859 CARDIAC PACEMAKER INSERTION 9
860 CARDIOMYOPATHY 9
861 CHEMICAL BURN OF SKIN 9
862 CHOLESTASIS 9
863 CHROMATURIA 9
864 COAGULOPATHY 9
865 CORNEAL ABRASION 9
866 DEAFNESS NEUROSENSORY 9
867 DELIRIUM 9
868 DUODENAL ULCER HAEMORRHAGE 9
869 EYE INFECTION BACTERIAL 9
870 EYE LASER SURGERY 9
871 EYELID SKIN DRYNESS 9
872 FEEDING DISORDER 9
873 GENERALISED OEDEMA 9
874 GINGIVAL BLEEDING 9
875 GRAVES^ DISEASE 9
876 HALO VISION 9
877 HELICOBACTER GASTRITIS 9
878 HEPATIC FUNCTION ABNORMAL 9
879 INCOHERENT 9
880 INCONTINENCE 9
881 INJECTION SITE MASS 9
882 KERATITIS INTERSTITIAL 9
883 LACERATION 9
884 LIP DRY 9
885 LOWER RESPIRATORY TRACT INFECTION 9
886 MALIGNANT MELANOMA 9
887 NERVE COMPRESSION 9
888 NORMOCYTIC ANAEMIA 9
889 OPTIC NERVE DISORDER 9
890 OROPHARYNGEAL DISCOMFORT 9
891 OSTEOPENIA 9
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9
893 POLYNEUROPATHY 9
894 PRODUCT LEAKAGE 9
895 RETINAL DEGENERATION 9
896 RETINAL OEDEMA 9
897 SCRATCH 9
898 SECRETION DISCHARGE 9
899 SHOCK 9
900 SINUS NODE DYSFUNCTION 9
901 SKIN HYPERPIGMENTATION 9
902 SLUGGISHNESS 9
903 SMALL INTESTINAL OBSTRUCTION 9
904 THERAPY PARTIAL RESPONDER 9
905 THYROID DISORDER 9
906 TRABECULECTOMY 9
907 VITRECTOMY 9
908 ADRENAL INSUFFICIENCY 8
909 ANAL INCONTINENCE 8
910 ANTERIOR CHAMBER DISORDER 8
911 ANTERIOR CHAMBER FIBRIN 8
912 APPLICATION SITE SWELLING 8
913 ASCITES 8
914 ASTIGMATISM 8
915 ATELECTASIS 8
916 ATRIOVENTRICULAR BLOCK 8
917 AUTOIMMUNE DISORDER 8
918 BLOOD PRESSURE SYSTOLIC ABNORMAL 8
919 BOWEL MOVEMENT IRREGULARITY 8
920 BRONCHOSPASM 8
921 CANDIDA INFECTION 8
922 CARDIAC FLUTTER 8
923 CARDIAC VALVE DISEASE 8
924 CATARACT SUBCAPSULAR 8
925 CEREBRAL HAEMATOMA 8
926 CHOLANGITIS 8
927 COLON CANCER 8
928 COORDINATION ABNORMAL 8
929 CORNEAL PERFORATION 8
930 DECUBITUS ULCER 8
931 DEMENTIA ALZHEIMER^S TYPE 8
932 DEVICE BREAKAGE 8
933 DEVICE FAILURE 8
934 DEVICE OCCLUSION 8
935 DRUG EFFECT LESS THAN EXPECTED 8
936 DUODENAL ULCER 8
937 ESSENTIAL HYPERTENSION 8
938 EXTRASYSTOLES 8
939 EYE CONTUSION 8
940 FLANK PAIN 8
941 FLAT ANTERIOR CHAMBER OF EYE 8
942 FOOT FRACTURE 8
943 GINGIVAL PAIN 8
944 GYNAECOMASTIA 8
945 HYPERTENSIVE CRISIS 8
946 INCORRECT DOSE ADMINISTERED BY DEVICE 8
947 INFECTIOUS CRYSTALLINE KERATOPATHY 8
948 INJURY ASSOCIATED WITH DEVICE 8
949 INSTILLATION SITE PRURITUS 8
950 INTENTIONAL OVERDOSE 8
951 JOINT EFFUSION 8
952 LOWER LIMB FRACTURE 8
953 MATERNAL EXPOSURE DURING PREGNANCY 8
954 MUSCLE STRAIN 8
955 NEPHROPATHY 8
956 NEPHROPATHY TOXIC 8
957 OPTIC ATROPHY 8
958 OSTEONECROSIS OF JAW 8
959 PARANASAL SINUS DISCOMFORT 8
960 PNEUMONIA HAEMOPHILUS 8
961 PNEUMOTHORAX 8
962 PRE-EXISTING CONDITION IMPROVED 8
963 PRODUCT CONTAMINATION 8
964 PRODUCT PHYSICAL CONSISTENCY ISSUE 8
965 PRODUCT PREPARATION ERROR 8
966 PULMONARY ARTERIAL PRESSURE INCREASED 8
967 PYELITIS 8
968 RENAL PAIN 8
969 RESPIRATION ABNORMAL 8
970 RHABDOMYOLYSIS 8
971 SCAR 8
972 SHORT STATURE 8
973 SINUS CONGESTION 8
974 SKIN SENSITISATION 8
975 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8
976 SPINAL DISORDER 8
977 SPINAL OPERATION 8
978 STREPTOCOCCAL INFECTION 8
979 SUPRAVENTRICULAR EXTRASYSTOLES 8
980 SUPRAVENTRICULAR TACHYCARDIA 8
981 THINKING ABNORMAL 8
982 VENTRICULAR EXTRASYSTOLES 8
983 VITREOUS OPACITIES 8
984 VOCAL CORD DISORDER 8
985 WITHDRAWAL SYNDROME 8
986 WOUND INFECTION 8
987 ABDOMINAL PAIN LOWER 7
988 ABSCESS LIMB 7
989 ANAPHYLACTIC SHOCK 7
990 BIPOLAR DISORDER 7
991 BLADDER CANCER 7
992 BLOOD BICARBONATE DECREASED 7
993 BLOOD POTASSIUM ABNORMAL 7
994 BONE LOSS 7
995 BRAIN INJURY 7
996 BRONCHIAL OBSTRUCTION 7
997 BURSITIS 7
998 CARDIAC MURMUR 7
999 CEREBRAL INFARCTION 7